CAPTOR THHERAP. ZY-10
Research CAPTOR THHERAP. ZY-10 (60Q) with Bullrun company financials, valuation charts, model signals, and historical stock context.
Key Metrics
- Ticker60Q
- ExchangeF
- CountryPoland
- CurrencyEUR
- Financial periodQ1 2026
- RevenueEUR 328.00K
- Net income-EUR 11.38M
- Free cash flow-EUR 12.66M
- Gross margin100.0%
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 4.66M | -EUR 42.00M | -EUR 37.53M | 69.0% | n/a | EUR 10.72M | EUR 3.58M | EUR 23.48M |
| FY2022 | PLN 9.16M | -PLN 35.89M | n/a | 77.2% | -8240 | PLN 71.04M | n/a | PLN 96.32M |
| FY2021 | PLN 3.99M | -PLN 32.57M | n/a | 81.4% | -7480 | PLN 117.94M | n/a | PLN 124.20M |
About CAPTOR THHERAP. ZY-10
General Information 1. The information on the Capital Group Captor Therapeutics S.A. (the "Company", "Entity", "Dominant Entity", or "Issuer") was entered into the Polish National Court Register on December 30, 2015, as a limited liability company under number KRS 0000594615, and subsequently transformed into an SA. The transformation of Captor Therapeutics Sp. z o.o. into Captor Therapeutics S.A.
Related stock research
Other related stocks
Frequently asked questions
What does CAPTOR THHERAP. ZY-10 do?
General Information 1. The information on the Capital Group Captor Therapeutics S.A. (the "Company", "Entity", "Dominant Entity", or "Issuer") was entered into the Polish National Court Register on December 30, 2015, as a limited liability company under number KRS 0000594615, and subsequently transformed into an SA. The transformation of Captor Therapeutics Sp. z o.o. into Captor Therapeutics S.A. was carried out in accordance with Article 551 of the Commercial Companies Code, based on a resolution of the Extraordinary General Meeting of Shareholders of Captor Therapeutics Sp. z o.o.